Anixa Biosciences(Anix) Financials: Gross Profit Margin Compared To Industry Average, Plus Other Key Ratios
Company Report for ANIX
Report - gross profit margin
This chart shows the historical trend of gross profit margin for ANIX compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Gross Profit Margin
Definition: Gross profit margin shows how much profit the company keeps from each dollar of sales after covering the direct cost of making its products or delivering services. High margins suggest strong pricing power or efficient production. Shrinking margins might mean rising costs or tougher competition eating into profits.
Interpretation:
• In '2021', ANIX's gross profit margin was 24.8%, showing profitability after production and operational costs. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at 56.8%.
• In '2023', ANIX's gross profit margin was 23.3%, showing profitability after production and operational costs. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 45.0%. Industry average declined by 11.8% from previous year.
Overall, ANIX's gross profit margin has remained generally stable over the past 2 years.
Formula: Gross Profit Margin = (Revenue - COGS) / Revenue
Good Range: Often 20%-60% depending on industry.